BOSTON, May 28, 2025 -- Aktis Oncology, Inc., an oncology company focused on unlocking the breakthrough potential of targeted radiopharmaceuticals for patient populations not addressed by existing platform technologies, today announced...
Two Pappas Ventures' Portfolio companies make FierceMedicalDevices' 2012 Fierce 15 list: CardioDx and TyRx
News | 10. 02. 2012
FierceMedicalDevices named two Pappas Ventures' portfolio companies to the 2012 Fierce 15 list, the inaugural list of the most innovative and exciting medical device companies. CardioDx is a cardiovascular molecular diagnostics company based in Palo Alto and TyRx is a New Jersey device company developing a range of drug-eluting implantable devices.
© 2025 Pappas Capital, LLC. ALL RIGHTS RESERVED.